Home/Neolys Diagnostics/Patrick Barhoum
PB

Patrick Barhoum

Business Developer

Neolys Diagnostics

Therapeutic Areas

Neolys Diagnostics Pipeline

DrugIndicationPhase
Radiosensitivity Predictive TestPrediction of radiotherapy toxicity/efficacy across cancer typesPre-clinical/Clinical Validation